Biotech · Private company · Independence, OH, US
Great Lakes NeuroTechnologies Inc.
Track this companyFree. Adds Great Lakes NeuroTechnologies Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Algorithm based programming using Kinesia-based assessmentParkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- DiSCERNParkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Kinesia 360 and Smartphone sensorsParkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ParkinPalParkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- DiSCERN: Advanced PD Therapy Candidacy and Evaluation SystemCOMPLETED · started Jul 21, 2022ClinicalTrials.gov NCT05351580 · fetched Nov 12, 2026
- Objective Quality of Life Detection ValidationCOMPLETED · started Sep 20, 2019ClinicalTrials.gov NCT04121793 · fetched Nov 12, 2026
- Patient-Centered PD Ambulatory Monitoring SystemUNKNOWN · started Jul 1, 2019ClinicalTrials.gov NCT04142528 · fetched Nov 12, 2026
- Automated Deep Brain Stimulation Programming Using Functional MappingNA · UNKNOWN · started Oct 1, 2018ClinicalTrials.gov NCT02765282 · fetched Nov 12, 2026
NIH awards3
- DiSCERN: Advanced PD Therapy Candidacy and Evaluation SystemFiscal year 2026 · $949.4KNIH RePORTER 2R44MD013767-04A1 · fetched Nov 12, 2026
- DBS-Expert Pro: Automated Deep Brain Stimulation Programming Using Functional MappingFiscal year 2026 · $926.7KNIH RePORTER 5R44NS143484-02 · fetched Nov 12, 2026
- DBS-Expert Pro: Automated Deep Brain Stimulation Programming Using Functional MappingFiscal year 2025 · $1.1MNIH RePORTER 1R44NS143484-01A1 · fetched Nov 12, 2026